Endoleak and thrombus characterization with dynamic elastography after endoleak embolization following aneurysm endovascular repair

Abstract

Event Abstract Back to Event Endoleak and thrombus characterization with dynamic elastography after endoleak embolization following aneurysm endovascular repair Antony Bertrand-Grenier1, 2, 3, 4, Fatemeh Zehtabi1, 5, 6, Claude Kauffman1, 3, Hélène Héon1, Guy Cloutier1, 2, 7, 8, Sophie Lerouge1, 5, 6 and Gilles Soulez1, 3, 7, 8, 9 1 Centre de Recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Canada 2 CRCHUM, Laboratoire de Biorhéologie et d’Ultrasonographie Médicale (LBUM), Canada 3 CRCHUM, Laboratoire Clinique de Traitement d’Images (LCTI), Canada 4 Université de Montréal, Département de Physique, Canada 5 CRCHUM, Laboratoire de Biomatériaux EndoVasculaire (LBEV), Canada 6 École de technologie supérieure (ÉTS), Département de génie mécanique, Canada 7 Université de Montréal, Institut de Génie Biomédical, Canada 8 Université de Montréal, Département de Radiologie, Radio-Oncologie et Médecine Nucléaire, Canada 9 Centre hospitalier de l’Université de Montréal (CHUM), Département de Radiologie, Canada Purpose: SuperSonic Imagine (SSI) measure the tissue elasticity in real-time[1]. The goal of this study was to characterize in a canine model of aneurysm endovascular repair (EVAR) residual endoleak[2] and thrombus organization[3] with SSI after endoleak embolization and correlate results with CT-Scan, Doppler Ultrasound (DUS) and pathologic findings. Materials and Methods: EVAR was done with creation of type I endoleak in eighteen aneurysms created in nine dogs (common iliacs arteries)[4]. Two embolization gels (Chitosan (Chi) or Chitosan-Sodium-Tetradecyl-Sulfate (Chi-STS)) were injected in the sac to seal the endoleak and promote healing[5]. SSI and DUS were performed at baseline (implantation, 1-week, 1-month, 3-months) whereas angiography and CT-scan were performed at sacrifice. Macroscopic and histopathological analyses were processed to identify and segment five different regions of interest (ROIs) (endoleak, fresh or organized thrombus, Chi or Chi-STS). Elasticity modulus values were compared. Results: At sacrifice, 10 aneurysms had type I endoleaks, 9 had fresh thrombus, 15 had organized thrombus and 3 were completely sealed. SSI was able to detect all endoleaks seen on CT-scan and macroscopic cuts. We found elastic moduli (in kPa) of 0.1 ± 0.2, 9.2 ± 3.5, 47.3 ± 25.7, 55.9 ± 21.7 and 69.6 ± 29.0 in endoleak, fresh thrombus, organized thrombus, Chi and Chi-STS regions at 3 months, respectively. Elasticity values of endoleak and fresh thrombus were significantly lower than others ROIs (p < 0.001). Figure 1 displays an AAA with different ROIs visualized with SSI. Figure 2 shows an aneurysm with massive fresh thrombus detected as an area of lower stiffness. Elasticity values of fresh thrombus ranged between 3 and 19 kPa (8.7 ± 3.6 kPa) at 1-week and 30.2 ± 13.8 kPa at 3-months indicating that SSI can evaluate thrombus maturation. Figure 1. Images from an aneurysm with endoleak (green arrow), chitosan (white arrow), chitosan less organized (yellow arrow) and organized thrombus (black arrow). Endoleak and fresh thrombus were visualized on SSI. Areas filled with Chi were slightly hyper echoic and with endoleak were anechoic on B-mode US. (A) Macroscopic cut. (B) CT-scan. (C) DUS. (D) B-mode US. (E) SSI. (F) Color scale values for SSI. Figure 2. Axial views of the different techniques from an aneurysm with massive fresh thrombus and a small endoleak saw on SSI. (A) Macroscopic cut. (B) CT-scan. (C) DUS. (D) B-mode US. (E) SSI. (F) Color scale values for SSI. The green, red and white arrows indicate endoleak, fresh thrombus and chitosan, respectively. Conclusion: The results confirm that SSI was able to evaluate thrombus organization and embolization agents over time after endoleak embolization following EVAR. A lower elastic modulus value corresponds to fresh thrombus wheres a higher value corresponds to organized thrombus. Clinical Relevance: The SSI can complement conventional DUS in post-EVAR surveillance. It could reduce the cost, the exposition to ionizing radiation and nephrotoxic contrast agents of surveillance CT-scan follow-up. Fonds de Recherche du Québec en Santé (FRQS); Canadian Institutes of Health Research